URMC Research Network

Find People
Keyword
Last Name
 
More Search Options

Scott McNitt

Concepts (322)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of pubs Most recent pub Pubs by all authors Concept score Why?
Defibrillators, Implantable
61
2004
377
7.070
Why?
Death, Sudden, Cardiac
38
2004
252
4.570
Why?
Long QT Syndrome
33
2005
359
4.290
Why?
Heart Failure
30
2004
360
3.710
Why?
Cardiac Resynchronization Therapy
18
2010
71
3.300
Why?
Ventricular Dysfunction, Left
25
2004
151
3.030
Why?
Myocardial Infarction
29
2005
651
2.910
Why?
Tachycardia, Ventricular
19
2004
147
2.500
Why?
Electrocardiography
38
2005
746
2.350
Why?
Proportional Hazards Models
38
2004
426
1.840
Why?
KCNQ1 Potassium Channel
9
2007
66
1.740
Why?
Ventricular Fibrillation
13
2004
90
1.630
Why?
Heart Arrest
16
2004
136
1.620
Why?
Risk Assessment
36
2004
875
1.580
Why?
Romano-Ward Syndrome
7
2007
31
1.570
Why?
Ether-A-Go-Go Potassium Channels
9
2006
51
1.560
Why?
Risk Factors
56
2004
2331
1.530
Why?
Male
114
1980
20139
1.490
Why?
Female
112
2004
20222
1.450
Why?
Adrenergic beta-Antagonists
18
2005
157
1.420
Why?
Mutation
12
2006
1226
1.310
Why?
Aged
67
2004
7392
1.290
Why?
Heart Conduction System
10
2004
146
1.270
Why?
Middle Aged
68
2004
10013
1.240
Why?
Electric Countershock
10
2004
90
1.220
Why?
Treatment Outcome
41
2004
2671
1.220
Why?
Heart Rate
14
2005
457
1.180
Why?
Atrial Fibrillation
7
2006
112
1.140
Why?
Humans
119
1978
37165
1.100
Why?
Syncope
12
2006
99
1.020
Why?
Kaplan-Meier Estimate
20
2007
207
0.990
Why?
Arrhythmias, Cardiac
9
2004
237
0.950
Why?
Stroke Volume
14
2005
144
0.930
Why?
Genotype
17
2007
473
0.900
Why?
Cardiomyopathies
6
2010
80
0.890
Why?
European Continental Ancestry Group
5
2006
238
0.840
Why?
Follow-Up Studies
29
2004
1889
0.830
Why?
Genetic Predisposition to Disease
12
2006
317
0.810
Why?
Adult
43
2005
11572
0.800
Why?
Myocardial Ischemia
8
2005
120
0.780
Why?
Survival Analysis
21
2004
589
0.750
Why?
Cause of Death
9
2004
158
0.750
Why?
African Continental Ancestry Group
3
2006
125
0.710
Why?
Young Adult
15
2008
1084
0.680
Why?
Arrhythmogenic Right Ventricular Dysplasia
1
2009
18
0.680
Why?
Hemostasis, Surgical
1
2008
11
0.670
Why?
Punctures
1
2008
23
0.670
Why?
Coagulants
1
2008
13
0.670
Why?
Survival Rate
18
2005
619
0.660
Why?
Ventricular Function, Left
4
2011
86
0.650
Why?
Femoral Artery
1
2008
75
0.650
Why?
Angioplasty, Balloon, Coronary
1
2008
64
0.640
Why?
Mutation, Missense
4
2007
89
0.640
Why?
Electrocardiography, Ambulatory
6
2007
92
0.620
Why?
Adolescent
23
2005
5044
0.620
Why?
Echocardiography
11
2007
217
0.610
Why?
Registries
13
2006
218
0.610
Why?
Chi-Square Distribution
12
2006
347
0.600
Why?
Prospective Studies
15
2005
1696
0.600
Why?
Time Factors
20
2004
3234
0.600
Why?
Prognosis
18
2004
1078
0.600
Why?
Hemorrhage
1
2008
181
0.590
Why?
Retrospective Studies
18
2004
2302
0.560
Why?
Heart Diseases
1
2006
138
0.530
Why?
Multivariate Analysis
13
2008
548
0.530
Why?
Child
17
2006
4342
0.530
Why?
Phenotype
9
2006
756
0.510
Why?
Incidence
11
2006
682
0.490
Why?
Ventricular Remodeling
4
2010
39
0.490
Why?
Recurrence
9
2006
697
0.470
Why?
Child, Preschool
14
2006
2737
0.450
Why?
Infant
13
2006
2320
0.450
Why?
Myocardial Contraction
3
2011
104
0.440
Why?
Heart
3
2010
239
0.390
Why?
Aza Compounds
4
2006
23
0.390
Why?
Sex Factors
10
2005
613
0.390
Why?
Quinolines
4
2006
44
0.380
Why?
Sodium Channels
3
2008
123
0.370
Why?
Smoking
3
2006
423
0.370
Why?
Jervell-Lange Nielsen Syndrome
2
2006
9
0.350
Why?
Diabetes Mellitus
2
2009
168
0.340
Why?
Myocardial Revascularization
2
2006
21
0.340
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
2
2006
46
0.340
Why?
Infant, Newborn
8
2007
1836
0.330
Why?
United States
8
2005
2847
0.320
Why?
Catheter Ablation
2
2009
81
0.320
Why?
Sequence Deletion
2
2007
128
0.320
Why?
Polymorphism, Genetic
3
2006
200
0.320
Why?
Muscle Proteins
2
2008
149
0.310
Why?
Codon, Nonsense
2
2007
54
0.310
Why?
Severity of Illness Index
9
2005
943
0.300
Why?
Membrane Potentials
2
2007
343
0.300
Why?
Cardiovascular Diseases
4
2004
275
0.290
Why?
Anti-Arrhythmia Agents
2
2006
82
0.290
Why?
Models, Molecular
2
2007
366
0.280
Why?
DNA
2
2011
862
0.280
Why?
Logistic Models
6
2004
626
0.280
Why?
Anti-Infective Agents
4
2006
78
0.270
Why?
Predictive Value of Tests
7
2005
609
0.270
Why?
Cohort Studies
9
2004
984
0.260
Why?
Statistics, Nonparametric
6
2004
269
0.250
Why?
Age Distribution
6
2007
227
0.250
Why?
Ventricular Premature Complexes
2
2008
18
0.250
Why?
Ion Channels
2
2010
153
0.230
Why?
Multicenter Studies as Topic
4
2004
127
0.230
Why?
Smoking Cessation
2
2006
95
0.230
Why?
Aged, 80 and over
9
2006
2588
0.230
Why?
Ventricular Dysfunction, Right
2
2009
18
0.230
Why?
Canada
2
2009
77
0.220
Why?
Tobacco Use Cessation Products
1
2012
3
0.220
Why?
Acute Coronary Syndrome
1
2012
7
0.220
Why?
Sex Distribution
5
2007
161
0.210
Why?
Age Factors
6
2006
1152
0.210
Why?
Diabetic Angiopathies
1
2012
34
0.210
Why?
Torsades de Pointes
2
2008
32
0.210
Why?
Risk
5
2004
355
0.200
Why?
Coronary Care Units
1
2011
17
0.200
Why?
Odds Ratio
5
2004
323
0.200
Why?
Heart-Assist Devices
1
2011
33
0.200
Why?
Cardiomyopathy, Dilated
1
2011
37
0.200
Why?
Angiotensin-Converting Enzyme Inhibitors
2
2006
50
0.200
Why?
Menopause
1
2011
38
0.200
Why?
Cardiac Resynchronization Therapy Devices
1
2011
12
0.200
Why?
Cardiac Pacing, Artificial
2
2010
158
0.200
Why?
Randomized Controlled Trials as Topic
4
2004
415
0.200
Why?
Age of Onset
2
2007
126
0.200
Why?
Heterozygote
2
2007
127
0.200
Why?
Patient Admission
1
2011
84
0.190
Why?
Heart Block
1
2011
59
0.190
Why?
Electrodes, Implanted
1
2011
56
0.190
Why?
Hypothermia, Induced
1
2010
28
0.190
Why?
Autonomic Nervous System
1
2010
70
0.190
Why?
Ambulatory Care
1
2011
167
0.190
Why?
Diagnosis, Computer-Assisted
2
2007
65
0.190
Why?
Electrophysiologic Techniques, Cardiac
2
2005
25
0.190
Why?
Polymorphism, Single Nucleotide
2
2007
90
0.180
Why?
Death
1
2010
23
0.180
Why?
Delayed Rectifier Potassium Channels
2
2006
10
0.180
Why?
Cardiomegaly
1
2010
49
0.180
Why?
Heart Atria
1
2010
63
0.180
Why?
Protein Structure, Secondary
1
2009
92
0.180
Why?
Ventricular Function, Right
2
2005
23
0.180
Why?
Ion Channel Gating
1
2011
125
0.170
Why?
Glomerular Filtration Rate
2
2006
82
0.170
Why?
Coronary Artery Bypass
1
2010
113
0.170
Why?
Cardiology
1
2010
55
0.170
Why?
Early Ambulation
1
2008
5
0.170
Why?
Angiography
1
2009
91
0.170
Why?
Ventricular Dysfunction
1
2008
8
0.170
Why?
Sotalol
1
2008
16
0.170
Why?
Acetanilides
1
2008
9
0.170
Why?
Body Mass Index
1
2010
229
0.170
Why?
Conserved Sequence
1
2009
104
0.170
Why?
Administration, Topical
1
2008
91
0.170
Why?
Models, Biological
2
2011
1029
0.170
Why?
Pressure
1
2008
144
0.160
Why?
Asian Continental Ancestry Group
1
2008
29
0.160
Why?
Adrenergic beta-Agonists
1
2008
54
0.160
Why?
Tachycardia, Supraventricular
1
2008
20
0.160
Why?
Siblings
1
2008
36
0.160
Why?
Atrial Flutter
1
2008
24
0.160
Why?
Physicians
1
2010
161
0.160
Why?
Genetic Variation
1
2008
147
0.160
Why?
Piperazines
1
2008
76
0.160
Why?
Cholesterol Ester Transfer Proteins
1
2007
14
0.160
Why?
Medical History Taking
1
2008
69
0.150
Why?
New York
5
2005
1378
0.150
Why?
Frameshift Mutation
1
2007
22
0.150
Why?
Japan
1
2007
29
0.150
Why?
RNA Splice Sites
1
2007
16
0.150
Why?
Netherlands
1
2007
28
0.150
Why?
Aryldialkylphosphatase
1
2007
5
0.150
Why?
Coronary Artery Disease
1
2008
88
0.150
Why?
African Americans
1
2010
230
0.150
Why?
Sodium
1
2008
306
0.150
Why?
Pregnancy, High-Risk
1
2007
13
0.150
Why?
Mutagenesis, Insertional
1
2007
50
0.150
Why?
Ion Transport
1
2007
70
0.150
Why?
Pregnancy Complications, Cardiovascular
1
2007
33
0.150
Why?
Hospitalization
5
2004
385
0.150
Why?
Probability
4
2004
306
0.150
Why?
Angiotensinogen
1
2006
7
0.150
Why?
Kidney
1
2010
589
0.150
Why?
Primary Prevention
1
2007
61
0.150
Why?
Bundle-Branch Block
3
2011
45
0.140
Why?
Nitric Oxide Synthase Type III
1
2007
73
0.140
Why?
Physician's Practice Patterns
1
2010
268
0.140
Why?
Attitude of Health Personnel
1
2010
302
0.140
Why?
Protein Transport
1
2007
170
0.140
Why?
Health Knowledge, Attitudes, Practice
1
2010
296
0.140
Why?
Mental Health
1
2007
85
0.140
Why?
Confidence Intervals
3
2007
164
0.140
Why?
Potassium
1
2007
309
0.140
Why?
Flecainide
1
2005
12
0.140
Why?
Pregnancy Outcome
1
2007
131
0.140
Why?
Kidney Failure, Chronic
1
2007
119
0.140
Why?
Tachycardia
1
2005
67
0.130
Why?
Protein Structure, Tertiary
1
2007
382
0.130
Why?
Diabetes Complications
1
2005
66
0.130
Why?
Blood Pressure
1
2007
468
0.130
Why?
Asthma
1
2008
314
0.120
Why?
Hypertension
1
2006
307
0.110
Why?
Obesity
1
2007
349
0.110
Why?
Spain
2
2012
18
0.110
Why?
Minnesota
2
2010
28
0.100
Why?
Echocardiography, Doppler
2
2011
38
0.100
Why?
Europe
2
2011
77
0.100
Why?
Sensitivity and Specificity
3
2006
914
0.100
Why?
World Health
2
2011
65
0.100
Why?
Systole
2
2009
39
0.090
Why?
Exercise
2
2010
181
0.090
Why?
Hospital Mortality
2
2008
137
0.090
Why?
Equipment Failure
2
2008
75
0.080
Why?
Blood Urea Nitrogen
2
2005
42
0.080
Why?
Clinical Trials as Topic
3
2004
685
0.080
Why?
Electrophysiology
2
2005
249
0.080
Why?
Analysis of Variance
2
2007
749
0.070
Why?
Regression Analysis
2
2007
539
0.070
Why?
Reproducibility of Results
2
2007
903
0.070
Why?
Pacemaker, Artificial
2
2008
163
0.070
Why?
Life Tables
2
2004
38
0.070
Why?
Disease Progression
2
2004
533
0.060
Why?
Algorithms
2
2007
543
0.060
Why?
Heart Function Tests
1
2012
31
0.050
Why?
Confounding Factors (Epidemiology)
1
2012
60
0.050
Why?
Precipitating Factors
1
2011
5
0.050
Why?
Disease-Free Survival
1
2012
204
0.050
Why?
Prosthesis Design
1
2011
64
0.050
Why?
Electric Conductivity
1
2011
88
0.050
Why?
Israel
1
2011
31
0.050
Why?
Estrogen Replacement Therapy
1
2011
21
0.050
Why?
Cardiotoxins
1
2011
3
0.050
Why?
Sleep
1
2011
58
0.050
Why?
Neuromuscular Nondepolarizing Agents
1
2011
14
0.050
Why?
Amino Acid Substitution
1
2011
133
0.050
Why?
Drug Evaluation, Preclinical
1
2011
79
0.050
Why?
Blood Volume
1
2010
52
0.050
Why?
Arousal
1
2010
56
0.050
Why?
Blood Circulation
1
2010
39
0.050
Why?
Monitoring, Physiologic
1
2010
110
0.050
Why?
DNA Mutational Analysis
1
2011
192
0.050
Why?
Creatinine
1
2010
131
0.050
Why?
Exercise Test
1
2010
99
0.050
Why?
Guidelines as Topic
1
2011
91
0.050
Why?
Case-Control Studies
1
2012
624
0.050
Why?
Oocytes
1
2011
136
0.050
Why?
Echocardiography, Transesophageal
1
2010
54
0.050
Why?
Xenopus laevis
1
2011
167
0.040
Why?
Family
1
2011
208
0.040
Why?
Heart Ventricles
1
2011
207
0.040
Why?
Organ Size
1
2010
194
0.040
Why?
Obesity, Morbid
1
2010
52
0.040
Why?
Drug Therapy, Combination
2
1978
397
0.040
Why?
Guideline Adherence
1
2010
87
0.040
Why?
Kidney Diseases
1
2011
170
0.040
Why?
Computer Simulation
1
2011
304
0.040
Why?
Continental Population Groups
1
2010
125
0.040
Why?
Health Care Surveys
1
2010
191
0.040
Why?
Physicians, Family
1
2010
116
0.040
Why?
Computational Biology
1
2009
66
0.040
Why?
Referral and Consultation
1
2010
207
0.040
Why?
Patient Selection
1
2010
223
0.040
Why?
Angina Pectoris
1
2008
50
0.040
Why?
Discriminant Analysis
1
2007
24
0.040
Why?
Point Mutation
1
2008
178
0.040
Why?
Postpartum Period
1
2007
37
0.040
Why?
Lipids
1
2007
166
0.040
Why?
Combined Modality Therapy
1
2008
491
0.040
Why?
Glutamine
1
2007
61
0.040
Why?
Parity
1
2007
47
0.040
Why?
Aspartic Acid
1
2007
48
0.040
Why?
Practice Guidelines as Topic
1
2010
319
0.040
Why?
Threonine
1
2006
30
0.040
Why?
Methionine
1
2006
49
0.040
Why?
Gene Frequency
1
2006
87
0.040
Why?
Homozygote
1
2006
95
0.040
Why?
Glutamic Acid
1
2007
101
0.040
Why?
Arginine
1
2007
120
0.040
Why?
Models, Cardiovascular
1
2006
68
0.030
Why?
ROC Curve
1
2006
130
0.030
Why?
Enzyme Inhibitors
1
2008
441
0.030
Why?
Nebraska
1
2005
6
0.030
Why?
Propanolamines
1
2005
12
0.030
Why?
Metoprolol
1
2005
10
0.030
Why?
Atenolol
1
2005
13
0.030
Why?
Gestational Age
1
2007
333
0.030
Why?
Placebo Effect
1
2005
36
0.030
Why?
Carbazoles
1
2005
29
0.030
Why?
Biological Markers
1
2008
564
0.030
Why?
Placebos
1
2006
185
0.030
Why?
Mortality
1
2006
91
0.030
Why?
Equipment Failure Analysis
1
2005
72
0.030
Why?
Amino Acid Sequence
1
2009
1227
0.030
Why?
Tomography, X-Ray Computed
1
2010
785
0.030
Why?
Equipment Design
1
2006
253
0.030
Why?
Outcome Assessment (Health Care)
1
2008
301
0.030
Why?
Survivors
1
2006
118
0.030
Why?
Action Potentials
1
2006
256
0.030
Why?
Prevalence
1
2007
582
0.030
Why?
Research Design
1
2006
340
0.030
Why?
Coronary Disease
1
2006
257
0.030
Why?
Comorbidity
1
2005
377
0.030
Why?
Molecular Sequence Data
1
2009
2046
0.030
Why?
Double-Blind Method
1
2005
996
0.030
Why?
Quality of Life
1
2007
528
0.030
Why?
Pregnancy
1
2007
1941
0.030
Why?
Doxorubicin
2
1978
105
0.030
Why?
Daunorubicin
1
1980
25
0.020
Why?
Neoplasms, Experimental
1
1980
149
0.020
Why?
Leukemia, Lymphoid
1
1978
64
0.020
Why?
Cyclophosphamide
1
1978
177
0.020
Why?
Animals
3
1978
16416
0.020
Why?
Leukemia, Experimental
2
1978
22
0.010
Why?
Melanoma
1
1980
132
0.010
Why?
Cell Survival
1
1980
559
0.010
Why?
DNA, Neoplasm
1
1978
129
0.000
Why?
Mice
2
1978
6206
0.000
Why?
Cell Count
1
1978
287
0.000
Why?
Drug Administration Schedule
1
1978
374
0.000
Why?
Kinetics
1
1980
1471
0.000
Why?
Bone Marrow
1
1978
292
0.000
Why?
Cell Line
1
1980
1623
0.000
Why?

Visualizations


McNitt's Networks

Concepts
_
Co-Authors
_
Similar People
_
Same Department